These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4488793)

  • 41. Genetic diease and human health, subject to cultural definitions.
    Calahan D
    Hastings Cent Rep; 1974 Sep; 4(4):6-7. PubMed ID: 4457509
    [No Abstract]   [Full Text] [Related]  

  • 42. Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease.
    Mittman C; Barbela T; Lieberman J
    J Occup Med; 1973 Jan; 15(1):33-8. PubMed ID: 4684725
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevalence of abnormal protease inhibitor phenotypes in patients with chronic obstructive lung disease.
    Mittman C; Lieberman J; Rumsfeld J
    Am Rev Respir Dis; 1974 Feb; 109(2):295-6. PubMed ID: 4811786
    [No Abstract]   [Full Text] [Related]  

  • 44. Hypersusceptibility and genetic problems in occupational medicine--a consensus report.
    Stokinger HE; Scheel LD
    J Occup Med; 1973 Jul; 15(7):564-73. PubMed ID: 4711647
    [No Abstract]   [Full Text] [Related]  

  • 45. Chronic obstructive lung diease: the result of the interaction of genetic and environmental factors.
    Mittman C
    Heart Lung; 1973; 2(2):222-6. PubMed ID: 4488793
    [No Abstract]   [Full Text] [Related]  

  • 46. [Role of congenital alpha-1-antitrypsin deficiency in the origin of chronic nonspecific lung diseases].
    Syromianikova NV; Timofeev NS; Gembitskaia TE
    Klin Med (Mosk); 1974 Dec; 52(12):11-5. PubMed ID: 4613948
    [No Abstract]   [Full Text] [Related]  

  • 47. [States of hyperdistention of the lung. II. Morphological characterization].
    Catena E
    Arch Monaldi; 1972; 27(5):621-66. PubMed ID: 4615646
    [No Abstract]   [Full Text] [Related]  

  • 48. [States of hyperdistention of the lung. IV. Brief review. Characteristic elements].
    Catena E; Marsico SA
    Arch Monaldi; 1972; 27(6):749-78. PubMed ID: 4615648
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetics of chronic obstructive pulmonary diseases. Searching for their heterogeneity.
    Kauffmann F
    Bull Eur Physiopathol Respir; 1984; 20(2):163-210. PubMed ID: 6372904
    [No Abstract]   [Full Text] [Related]  

  • 50. The pathogenesis of chronic obstructive lung diseases: implications for therapy.
    Stockley RA
    QJM; 1995 Feb; 88(2):141-6. PubMed ID: 7704565
    [No Abstract]   [Full Text] [Related]  

  • 51. Genetics of chronic obstructive pulmonary disease.
    Silverman EK
    Novartis Found Symp; 2001; 234():45-58; discussion 58-64. PubMed ID: 11199103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin.
    Fagerhol MK; Cox DW
    Adv Hum Genet; 1981; 11():1-62, 371-2. PubMed ID: 6168185
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiovascular involvement in metabolic diseases.
    Gilbert-Barness E
    Pediatr Pathol Mol Med; 2002; 21(2):93-136. PubMed ID: 11942539
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.